Indices trade with minor gains; Sensex adds 136 pts; PSU banks advance

Image
Capital Market
Last Updated : Jan 16 2023 | 10:50 AM IST
The domestic equity benchmarks traded with small gains in morning trade. The Nifty traded above the key 17,950 mark. PSU banks advanced for the second day in a row.

At 10:28 IST, the barometer index, the S&P BSE Sensex, was up 136.31 points or 0.23% to 60,397.49. The Nifty 50 index added 17.45 points or 0.09% to 17,974.05.

In the broader market, the S&P BSE Mid-Cap index rose 0.21% while the S&P BSE Small-Cap index gained 0.32%.

The market breadth was strong. On the BSE, 1,883 shares rose, and 1,403 shares fell. A total of 168 shares were unchanged.

Foreign portfolio investors (FPIs) sold shares worth Rs 2,422.39 crore, while domestic institutional investors (DIIs), were net buyers to the tune of Rs 1,953.40 crore in the Indian equity market on 13 January, provisional data showed.

Earnings Today:

Angel One (up 0.70%), Federal Bank (up 1.44%), JSW Ispat Special Products (down 1.83), Kesoram Industries (up 1.33%), Bank of Maharashtra (up 3.47%) and Tinplate Company of India (down 0.48%) will announce their quarterly results later today.

Buzzing Index:

The Nifty PSU Bank index gained 1.72% to 4,353.75, extending gains for the second day. The index jumped 3.09% in three trading sessions.

UCO Bank (up 6.66%), Indian Overseas Bank (up 5.16%), Central Bank of India (up 4.89%), Punjab & Sind Bank (up 4.44%), Union Bank of India (up 4.06%), Bank of Maharashtra (up 3.79%), Bank of India (up 3.16%), Indian Bank (up 2.86%), Punjab National Bank (up 2.64%) and Bank of Baroda (up 1.35%) were the gainers.

Stocks in Spotlight:

Zydus Lifesciences declined 0.53%. The drug maker's (formerly known as Cadila Healthcare) subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus) has received tentative approval from the United States Food and Drug Administration (USFDA) to market Levomilnacipran extended-release capsules, 20 mg, 40 mg, 80 mg, and 120 mg (USRLD: Fetzima extended-release capsules).

Just Dial hit an upper circuit of 10% after the company reported a consolidated net profit of Rs 75.32 crore in Q3 FY23, steeply higher than Rs 19.39 crore posted in Q3 FY22. Net revenue from operations stood at Rs 221.37 crore in Q3 FY23, registering a growth of 39.3% from Rs 158.89 crore recorded in the corresponding quarter previous year.

L&T Finance Holdings rallied 3.19% after the company's consolidated net profit jumps 39.2% to Rs 453.64 crore in in Q3 FY23 as against Rs 325.99 crore posted in Q3 FY22. Total income soared 80% to Rs 5,671.60 crore in quarter ended 31 December 2022 from Rs 3,150.50 crore recorded in Q3 FY22.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 16 2023 | 10:32 AM IST

Next Story